Aprepitant and Pseudo-obstruction - intestinal - from FDA reports


Pseudo-obstruction - intestinal is found among people who take Aprepitant, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Dexamethasone, and have Preventive health care. This review analyzes which people have Pseudo-obstruction - intestinal with Aprepitant. It is created by eHealthMe based on reports of 1,879 people who have side effects when taking Aprepitant from FDA, and is updated regularly.



On Jul, 17, 2018

1,879 people reported to have side effects when taking Aprepitant.
Among them, 24 people (1.28%) have Pseudo-obstruction - intestinal


Number of reports submitted per year:

Could Aprepitant cause Pseudo-obstruction - intestinal?

Time on Aprepitant when people have Pseudo-obstruction - intestinal *:

  • < 1 month: 85.71 %
  • 1 - 6 months: 14.29 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Pseudo-obstruction - intestinal when taking Aprepitant *:

  • female: 54.17 %
  • male: 45.83 %

Age of people who have Pseudo-obstruction - intestinal when taking Aprepitant *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 8.7 %
  • 40-49: 4.35 %
  • 50-59: 26.09 %
  • 60+: 60.87 %

Top conditions involved for these people *:

  1. Preventive Health Care: 6 people, 25.00%
  2. Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 5 people, 20.83%
  3. Hodgkin's Lymphoma (cancer originating from white blood cells): 4 people, 16.67%
  4. Gastroesophageal Cancer: 3 people, 12.50%
  5. Cough: 3 people, 12.50%

Top co-used drugs for these people *:

  1. Palonosetron: 9 people, 37.50%
  2. Dexamethasone: 9 people, 37.50%
  3. Cisplatin: 8 people, 33.33%
  4. Ibuprofen: 7 people, 29.17%
  5. Ondansetron: 7 people, 29.17%

Top other side effects for these people *:

  1. Nausea And Vomiting: 9 people, 37.50%
  2. Dehydration (dryness resulting from the removal of water): 9 people, 37.50%
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 29.17%
  4. Thrombocytopenia (decrease of platelets in blood): 6 people, 25.00%
  5. White Blood Cell Count Decreased: 6 people, 25.00%

* Approximation only. Some reports may have incomplete information.

What's next:

You could also:



Related studies

Aprepitant

Aprepitant has active ingredients of aprepitant. (latest outcomes from Aprepitant 1,882 users)

Pseudo-obstruction - intestinal

Pseudo-obstruction - intestinal (a motility disorder with symptoms like those of a bowel blockage, but with no physical evidence of blockage or obstruction) has been reported by people with crohn's disease, acne, high blood pressure, pain (latest reports from 28,515 Pseudo-obstruction - intestinal patients).


Drugs that are associated with Pseudo-obstruction - intestinal
Pseudo-obstruction - intestinal (1,175 drugs)
Could your condition cause Pseudo-obstruction - intestinal
Pseudo-obstruction - intestinal (1,841 conditions)
Aprepitant side effects
Browse all side effects of Aprepitant
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Aprepitant and have Pseudo-obstruction - intestinal


You are not alone. Join our personalized support groups:


You may be interested in these posts

More posts for: Aprepitant, Pseudo-obstruction - intestinal

Recent updates

General studies
Active Support Groups
Latest posts

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.